https://www.selleckchem.com/products/ten-010.html
The treatment with ATV at different doses elevated NO level and RHI and declined ET-1 content. Gastrointestinal reaction, muscular pain, and increased aminopherase were observed after treatment with the ATV at different doses with more obvious symptoms detected accompanied by the increase of the dose. The RHI was in negative correlation with the ET-1 and HS-CRP while in positive correlation with NO. CONCLUSION Our study demonstrates that ATV can significantly improve the vascular endothelial function in LA patients with a dose-dependent
Aimer
Commentaire
Partagez
